Search Results - "Labrie, Bridget"

A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma by Ness, Dylan B., Pooler, Darcy B., Ades, Steven, Highhouse, Brian J., Labrie, Bridget M., Zhou, Jie, Gui, Jiang, Lewis, Lionel D., Ernstoff, Marc S.

“…Background Sunitinib is a multi‐target tyrosine kinase inhibitor (TKI) that inhibits VEGF receptor 1, 2, 3 (VEGFRs), platelet‐derived growth factor receptor…”
Get full text

A phase I trial of BNC105P and ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia by Pooler, Darcy B., Ness, Dylan B., Danilov, Alexey V., Labrie, Bridget M., Tosteson, Tor D., Eastman, Alan, Lewis, Lionel D., Lansigan, Frederick

“…Targeted therapies such as the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib are better tolerated and have become standard of care for CLL. TABLE 1…”
Get full text

Caregivers’ Out-of-Pocket Expenses and Time Commitment Following Hematopoietic Stem Cell Transplantation at a Rural Cancer Center by Meehan, Kenneth R., Meehan, John M., Hill, John M., Caldon, Kate L., Root, Lynn D., Labrie, Bridget, Brighton, Susan, Hayes, Christi Ann, Lowrey, Christopher H.

“…•Transplantation is a complicated and prolonged process for patients.•The out-of-pocket expenses and time commitment for caregivers of transplant recipients…”
Get full text